Scroll To Top
Health

Geron Corp.'s
compounds show promise in fighting HIV

Geron Corp.'s
compounds show promise in fighting HIV

Support The Advocate
We're asking for your help to continue our newsroom's important reporting. Support LGBTQ+ journalism by contributing today!

Geron Corp. announced that research on two of its compounds have show that they help the body's own immune cells in fighting the production of viruses in HIV-infected cells. The compounds, small molecule telomerase activators named TAT0001 and TAT0002, enhanced the ability of CD8+ T cells to kill other HIV-infected immune cells, the research demonstrated. During the progression of HIV, CD8+ cells age faster than normal and lose their ability to kill off immune cells that have been infected with HIV. (AP)

30 Years of Out100Out / Advocate Magazine - Jonathan Groff & Wayne Brady

From our Sponsors

Most Popular

Latest Stories

Outtraveler Staff